313 related articles for article (PubMed ID: 26988258)
1. Status of vaccine research and development of vaccines for GBS.
Heath PT
Vaccine; 2016 Jun; 34(26):2876-2879. PubMed ID: 26988258
[TBL] [Abstract][Full Text] [Related]
2. An overview of global GBS epidemiology.
Le Doare K; Heath PT
Vaccine; 2013 Aug; 31 Suppl 4():D7-12. PubMed ID: 23973349
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
[TBL] [Abstract][Full Text] [Related]
4. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
[TBL] [Abstract][Full Text] [Related]
5. Prospects for preventing infant invasive GBS disease through maternal vaccination.
Madhi SA; Dangor Z
Vaccine; 2017 Aug; 35(35 Pt A):4457-4460. PubMed ID: 28237500
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
[TBL] [Abstract][Full Text] [Related]
7. Group B streptococcal epidemiology and vaccine needs in developed countries.
Melin P; Efstratiou A
Vaccine; 2013 Aug; 31 Suppl 4():D31-42. PubMed ID: 23973345
[TBL] [Abstract][Full Text] [Related]
8. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
Schrag SJ; Verani JR
Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
[TBL] [Abstract][Full Text] [Related]
9. Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination.
Edwards MS; Gonik B
Vaccine; 2013 Aug; 31 Suppl 4():D66-71. PubMed ID: 23200934
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
[TBL] [Abstract][Full Text] [Related]
11. The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus.
Berardi A; Cassetti T; Creti R; Vocale C; Ambretti S; Sarti M; Facchinetti F; Cose S; ; Heath P; Le Doare K
Ital J Pediatr; 2020 Oct; 46(1):160. PubMed ID: 33115542
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis.
Jordan HT; Farley MM; Craig A; Mohle-Boetani J; Harrison LH; Petit S; Lynfield R; Thomas A; Zansky S; Gershman K; Albanese BA; Schaffner W; Schrag SJ;
Pediatr Infect Dis J; 2008 Dec; 27(12):1057-64. PubMed ID: 18989238
[TBL] [Abstract][Full Text] [Related]
13. Neonatal group B streptococcus disease in developing countries: are we ready to deploy a vaccine?
Iroh Tam PY; Delair SF; Obaro SK
Expert Rev Vaccines; 2015; 14(11):1401-3. PubMed ID: 26289974
[TBL] [Abstract][Full Text] [Related]
14. [Maternal and perinatal infections to Streptococcus agalactiae].
Six A; Joubrel C; Tazi A; Poyart C
Presse Med; 2014 Jun; 43(6 Pt 1):706-14. PubMed ID: 24855049
[TBL] [Abstract][Full Text] [Related]
15. Group B Streptococcus: Trials and Tribulations.
Davies HG; Carreras-Abad C; Le Doare K; Heath PT
Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S72-S76. PubMed ID: 31205250
[TBL] [Abstract][Full Text] [Related]
16. Disease burden of neonatal invasive Group B Streptococcus infection in the Netherlands.
de Gier B; van Kassel MN; Sanders EAM; van de Beek D; Hahné SJM; van der Ende A; Bijlsma MW
PLoS One; 2019; 14(5):e0216749. PubMed ID: 31071191
[TBL] [Abstract][Full Text] [Related]
17. 20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention.
Paul P; Gonçalves BP; Le Doare K; Lawn JE
Curr Opin Pediatr; 2023 Apr; 35(2):223-230. PubMed ID: 36749143
[TBL] [Abstract][Full Text] [Related]
18. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Verani JR; McGee L; Schrag SJ;
MMWR Recomm Rep; 2010 Nov; 59(RR-10):1-36. PubMed ID: 21088663
[TBL] [Abstract][Full Text] [Related]
19. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
[TBL] [Abstract][Full Text] [Related]
20. Glycoconjugate vaccines to prevent group B streptococcal infections.
Paoletti LC; Kasper DL
Expert Opin Biol Ther; 2003 Sep; 3(6):975-84. PubMed ID: 12943456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
